Log in Problems?
 New User? Sign Up!

imedecin.fr

La préménopause

Insomnie et cancer

Cancers du col de l’utérus, du vagin et de la vulve

Utilisation de l'airelle

Euthanasie ou droit à la souffrance

Etreinte immunologique

Le sommeil des enfants

Un nouveau centre d'imagerie Hight-Tech

L’épidémie de grippe devrait arriver à son terme

Hypertension et troubles cognitifs.

Imedecin.com

Hémorragies et défaillances circulatoires aigues

La douleur en sémiologie digestive

Endocrinologie - Œstrogène et progestérone

Anatomie descriptive du poumon

Endocrinologie des ovaires

Evolution des cancers en dehors des traitements

L'athérosclérose, athérome, athéromatose

Cryptosporidium parvum

Histologie des testicules

Trichinose ou Trichinellose

Le virus de l’hépatite B

Les corticosurrénales

Les médicaments anti-arythmiques

Les causes de l’ischémie

Diagnostic de la grossesse

Langue préférée :

Deutsch English Español
Français dansk suomi

 

There are 4 unlogged users and 0 registered users online.

You can log-in or register for a user account here.

Sites imedecin

Médecine et mobilité
Médecine et informatique
imedecin.org




_HOME | _RSS

Scientific American - News Items


newsp.gif
Growing Prostates from Adult Stem Cells--But Who Would Want One?
Wednesday, October 22, 2008 - 04:00 PM - 1 month, 1 week ago   -  Cancer  -  Scientific American
Researchers report today that they grew prostate glands--important for reproduction in male mammals--in mice using a single stem cell transplanted from the prostates of donor mice. The findings may pave the way to new therapies for prostate cancer, which strikes one in six men in the U.S. [More]
Mapping the Spine, Gene by Gene
Sunday, October 12, 2008 - 10:00 PM - 1 month, 2 weeks ago   -  Cancer  -  Scientific American
Spinal cord injuries and disorders afflict millions worldwide, from disabled veterans to people with neurodegenerative disorders such as Lou Gehrig’s disease, yet there is currently no way to repair a damaged spine. Geneticists at the Allen Institute for Brain Science in Seattle are hoping to change that by developing the first genetic encyclopedia of the spinal cord.The Allen Spinal Cord Atlas, which will be available online for free in early 2009, will map out which genes are active in which locations along the spine in mice, which share 90 percent of their genetic material with humans. [More]
How Green Was the Nobel Prize in Chemistry
Wednesday, October 08, 2008 - 05:04 AM - 1 month, 3 weeks ago   -  Cancer  -  Scientific American
[The following is an exact transcript of this podcast.]The Nobel Prize in chemistry goes to three men who revolutionized molecular life science, Japan’s Osamu Shimomura and Americans Martin Chalfie and Roger Tsien. They developing tools to light up and see individual proteins inside living cells. These tiny molecular flashlights make it possible to study numerous events that take place in cells and whole organisms that were previously invisible--such as the development of nerve cells or the spread of cancer cells. [More]
What makes pancreatic cancer so deadly?
Monday, August 25, 2008 - 03:00 PM - 3 months, 1 week ago   -  Cancer  -  Scientific American
Gene Upshaw, the executive director of the National Football League Player's Association--the union for NFL players--died late Wednesday evening of pancreatic cancer while vacationing in California's Lake Tahoe. Doctors diagnosed the 63-year-old Hall of Fame offensive lineman with the disease just four days earlier. [More]
Antibody Drug Unleashes Tumor-Killer T Cells
Friday, August 15, 2008 - 10:00 AM - 3 months, 2 weeks ago   -  Cancer  -  Scientific American
Scientists have developed a two-pronged protein that grabs immune system cells with one arm and introduces them to cancer cells it has snagged with the other. The result: eradicated tumors--at certain doses. [More]
Cancer Drug Costs May Help Doctors Select a Treatment
Monday, August 11, 2008 - 10:00 PM - 3 months, 3 weeks ago   -  Cancer  -  Scientific American
Oncologists will soon be adding “financial counselor” to their job description. With an increasing number of cancer patients suffering economic hardships as a side effect of expensive therapy, most oncologists are finding that cost needs to be considered as part of treatment options. Leading cancer organizations are now working on incorporating cost into treatment guidelines and other materials. The change, which departs from the current American medical ethos, is fraught with thorny questions not only for cancer doctors and patients but also for the health care system at large.The U.S. spends about $200 billion annually on cancer care; many new drugs cost several thousand dollars monthly. For patients, co-payments represent the most severe sappers of bank accounts. Increasingly, insurers are holding patients accountable for up to 20 percent of the prescription price. Covered drugs being used off-label (for an indication not formally approved but still medically appropriate) can carry co-pays of up to 30 percent. [More]
Lensless On-Chip Microscope Inspired by "Floaters" in the Eye [News]
Tuesday, July 29, 2008 - 05:00 AM - 4 months ago   -  Cancer  -  Scientific American
Researchers hope that a new kind of small portable microscope may give health workers the ability to quickly and cheaply scan blood for tumor cells and life-threatening parasites. [More]
Lensless On-Chip Microscope Inspired by "Floaters" in the Eye
Tuesday, July 29, 2008 - 05:00 AM - 4 months ago   -  Cancer  -  Scientific American
Researchers hope that a new kind of small portable microscope may give health workers the ability to quickly and cheaply scan blood for tumor cells and life-threatening parasites. [More]
Good and Evil: A Cancer Vaccine from Tobacco Plants [News]
Tuesday, July 22, 2008 - 12:00 PM - 4 months, 1 week ago   -  Cancer  -  Scientific American
In the first human trial of its kind, a vaccine grown in genetically engineered tobacco plants has proved to be safe, paving the way to one day use it to help combat a potentially fatal form of non-Hodgkin's lymphoma. [More]
Good and Evil: A Cancer Vaccine from Tobacco Plants
Tuesday, July 22, 2008 - 12:00 PM - 4 months, 1 week ago   -  Cancer  -  Scientific American
In the first human trial of its kind, a vaccine grown in genetically engineered tobacco plants has proved to be safe, paving the way to one day use it to help combat a potentially fatal form of non-Hodgkin's lymphoma. [More]

    123456789   >

News Provided by: Scientific American